{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:29:48Z","timestamp":1759336188503,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["CAN 2017\/464","CAN 21 1408 Pj"],"award-info":[{"award-number":["CAN 2017\/464","CAN 21 1408 Pj"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013491","name":"Jane och Dan Olssons Stiftelse","doi-asserted-by":"publisher","award":["2016-49"],"award-info":[{"award-number":["2016-49"]}],"id":[{"id":"10.13039\/501100013491","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish governmental grants to researchers in the public health service","award":["ALFGBG- 720291","ALFGBG-965130"],"award-info":[{"award-number":["ALFGBG- 720291","ALFGBG-965130"]}]},{"name":"Swedish governmental grants to researchers in the public health service","award":["ALFVLL-7000001","ALF VLL-7000003","ALFRV-7000003"],"award-info":[{"award-number":["ALFVLL-7000001","ALF VLL-7000003","ALFRV-7000003"]}]},{"name":"Governmental funding after regional HTA","award":["HTA ALF 2016-86","2017-01832"],"award-info":[{"award-number":["HTA ALF 2016-86","2017-01832"]}]},{"DOI":"10.13039\/100017138","name":"Health and Medical Care Committee of the Regional Executive Board, Region V\u00e4stra G\u00f6taland","doi-asserted-by":"publisher","award":["VGFOUREG-650491","VGFOUREG-940745"],"award-info":[{"award-number":["VGFOUREG-650491","VGFOUREG-940745"]}],"id":[{"id":"10.13039\/100017138","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004886","name":"Cancer Research Foundation in Northern Sweden","doi-asserted-by":"publisher","award":["AMP 17-859","LP 17-2169","LP 22-2314"],"award-info":[{"award-number":["AMP 17-859","LP 17-2169","LP 22-2314"]}],"id":[{"id":"10.13039\/501100004886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019032","name":"Regionala Forskningsr\u00e5det Uppsala\/\u00d6rebro","doi-asserted-by":"publisher","award":["RFR 652-621"],"award-info":[{"award-number":["RFR 652-621"]}],"id":[{"id":"10.13039\/100019032","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Umea University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The HOPPSA trial is a multi-center national registry-based randomized controlled trial to test the safety and effectiveness of performing opportunistic salpingectomy at hysterectomy to reduce the risk of epithelial ovarian cancer (EOC). The study protocol was first published in January 2019 and is available at <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-018-3083-8\">https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-018-3083-8<\/jats:ext-link>. Here, we report amendments made to the study protocol since commencement of the trial.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Changes in methods and analysis<\/jats:title>\n                <jats:p>The primary outcomes analyses have been changed. (1) <jats:italic>Complications<\/jats:italic> will be analyzed using binomial generalized estimating equation (GEE) with log link function, while the unadjusted analyses according to Miettinen and Nurminen will be performed as a sensitivity analysis. (2) Absolute change in <jats:italic>Menopause Rating Scale<\/jats:italic> (MRS) will primarily be analyzed using a mixed effects model, adjusted for baseline MRS and <jats:italic>center<\/jats:italic> as a random effect. (3) <jats:italic>Time to EOC<\/jats:italic> will be analyzed using the mixed effects Cox regression model with <jats:italic>center<\/jats:italic> as random effect, while the unadjusted log-rank test will be performed as a sensitivity analysis.<\/jats:p>\n                <jats:p>The primary outcome <jats:italic>Complications<\/jats:italic> will be based solely on the specific assessment in\u00a0the GynOp\u00a0quality registry. The Clavien-Dindo classification will be evaluated as a secondary outcome.<\/jats:p>\n                <jats:p>Furthermore, MRS is also measured three years postoperatively to better pinpoint the onset of menopausal symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>The changes to the protocol mainly concern the analyses of data. No changes to recruitment, randomization, intervention, or follow-up of primary outcomes have been made. An interim analysis during 2021 concluded that the study should continue until the target sample size is reached.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/NCT03045965\">NCT03045965<\/jats:ext-link>. Registered 8 February 2017.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-023-07244-w","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T03:02:42Z","timestamp":1679626962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["HOPPSA update: changes in the study protocol of Hysterectomy and OPPortunistic SAlpingectomy, a registry-based randomized controlled trial"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7865-4560","authenticated-orcid":false,"given":"Annika","family":"Idahl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Liv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Darelius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elin","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Sundfeldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"P\u00e5lsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annika","family":"Strandell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,24]]},"reference":[{"issue":"2","key":"7244_CR1","doi-asserted-by":"publisher","first-page":"dju410","DOI":"10.1093\/jnci\/dju410","volume":"107","author":"H Falconer","year":"2015","unstructured":"Falconer H, Yin L, Gronberg H, Altman D. Ovarian cancer risk after salpingectomy: a nationwide population-based study. J Natl Cancer Inst. 2015;107(2):dju410. https:\/\/doi.org\/10.1093\/jnci\/dju410.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"7244_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/aogs.12516","volume":"94","author":"C Madsen","year":"2015","unstructured":"Madsen C, Baandrup L, Dehlendorff C, Kjaer SK. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study. Acta Obstet Gynecol Scand. 2015;94(1):86\u201394. https:\/\/doi.org\/10.1111\/aogs.12516.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"7244_CR3","doi-asserted-by":"publisher","first-page":"CD012858","DOI":"10.1002\/14651858.CD012858.pub2","volume":"8","author":"LAM van Lieshout","year":"2019","unstructured":"van Lieshout LAM, Steenbeek MP, De Hullu JA, et al. Hysterectomy with opportunistic salpingectomy versus hysterectomy alone. Cochrane Database Syst Rev. 2019;8:CD012858. https:\/\/doi.org\/10.1002\/14651858.CD012858.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"7244_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13063-018-3083-8","volume":"20","author":"A Idahl","year":"2019","unstructured":"Idahl A, Darelius A, Sundfeldt K, Palsson M, Strandell A. Hysterectomy and opportunistic salpingectomy (HOPPSA): study protocol for a register-based randomized controlled trial. Trials. 2019;20(1):10. https:\/\/doi.org\/10.1186\/s13063-018-3083-8.","journal-title":"Trials"},{"key":"7244_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1477-7525-2-45","volume":"2","author":"K Heinemann","year":"2004","unstructured":"Heinemann K, Ruebig A, Potthoff P, et al. The Menopause Rating Scale (MRS) scale: a methodological review. Health Qual Life Outcomes. 2004;2:45. https:\/\/doi.org\/10.1186\/1477-7525-2-45.","journal-title":"Health Qual Life Outcomes"},{"key":"7244_CR6","unstructured":"GynOp - The swedish national quality register of gynecological surgery. (https:\/\/www.gynop.se\/home\/). Accessed 24 Jan 2022."},{"issue":"1","key":"7244_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12874-016-0217-0","volume":"16","author":"C Pedroza","year":"2016","unstructured":"Pedroza C, Truong VT. Performance of models for estimating absolute risk difference in multicenter trials with binary outcome. BMC Med Res Methodol. 2016;16(1):113. https:\/\/doi.org\/10.1186\/s12874-016-0217-0.","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"7244_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/sim.4780040211","volume":"4","author":"O Miettinen","year":"1985","unstructured":"Miettinen O, Nurminen M. Comparative analysis of two rates. Stat Med. 1985;4(2):213\u201326. https:\/\/doi.org\/10.1002\/sim.4780040211.","journal-title":"Stat Med"},{"key":"7244_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1471-2288-13-99","volume":"13","author":"BC Kahan","year":"2013","unstructured":"Kahan BC, Morris TP. Adjusting for multiple prognostic factors in the analysis of randomised trials. BMC Med Res Methodol. 2013;13:99. https:\/\/doi.org\/10.1186\/1471-2288-13-99.","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"7244_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/sim.4431","volume":"31","author":"BC Kahan","year":"2012","unstructured":"Kahan BC, Morris TP. Improper analysis of trials randomised using stratified blocks or minimisation. Stat Med. 2012;31(4):328\u201340. https:\/\/doi.org\/10.1002\/sim.4431.","journal-title":"Stat Med"},{"issue":"2","key":"7244_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae.","journal-title":"Ann Surg"},{"issue":"1","key":"7244_CR12","doi-asserted-by":"publisher","first-page":"85 e1","DOI":"10.1016\/j.ajog.2018.10.016","volume":"220","author":"E Collins","year":"2019","unstructured":"Collins E, Strandell A, Granasen G, Idahl A. Menopausal symptoms and surgical complications after opportunistic bilateral salpingectomy, a register-based cohort study. Am J Obstet Gynecol. 2019;220(1):85 e1-85 e10. https:\/\/doi.org\/10.1016\/j.ajog.2018.10.016.","journal-title":"Am J Obstet Gynecol"},{"issue":"19","key":"7244_CR13","doi-asserted-by":"publisher","first-page":"11871","DOI":"10.3390\/ijerph191911871","volume":"19","author":"PC Chen","year":"2022","unstructured":"Chen PC, Li PC, Ding DC. Possible association of hysterectomy accompanied with opportunistic salpingectomy with early menopause: a retrospective cohort study. Int J Environ Res Public Health. 2022;19(19):11871. https:\/\/doi.org\/10.3390\/ijerph191911871.","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"7244_CR14","doi-asserted-by":"publisher","first-page":"221 e1","DOI":"10.1016\/j.ajog.2020.02.005","volume":"223","author":"GE Hanley","year":"2020","unstructured":"Hanley GE, Kwon JS, McAlpine JN, Huntsman DG, Finlayson SJ, Miller D. Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada. Am J Obstet Gynecol. 2020;223(2):221 e1-221 e11. https:\/\/doi.org\/10.1016\/j.ajog.2020.02.005.","journal-title":"Am J Obstet Gynecol"},{"key":"7244_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.maturitas.2022.08.002","volume":"166","author":"ME Gelderblom","year":"2022","unstructured":"Gelderblom ME, IntHout J, Dagovic L, Hermens R, Piek JMJ, de Hullu JA. The effect of opportunistic salpingectomy for primary prevention of ovarian cancer on ovarian reserve: a systematic review and meta-analysis. Maturitas. 2022;166:21\u201334. https:\/\/doi.org\/10.1016\/j.maturitas.2022.08.002.","journal-title":"Maturitas"},{"issue":"6","key":"7244_CR16","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1111\/1471-0528.14601","volume":"124","author":"A Darelius","year":"2017","unstructured":"Darelius A, Lycke M, Kindblom JM, Kristjansdottir B, Sundfeldt K, Strandell A. Efficacy of salpingectomy at hysterectomy to reduce the risk of epithelial ovarian cancer: a systematic review. BJOG. 2017;124(6):880\u20139. https:\/\/doi.org\/10.1111\/1471-0528.14601.","journal-title":"BJOG"},{"issue":"2","key":"7244_CR17","doi-asserted-by":"publisher","first-page":"172 e1","DOI":"10.1016\/j.ajog.2018.05.019","volume":"219","author":"GE Hanley","year":"2018","unstructured":"Hanley GE, Kwon JS, Finlayson SJ, Huntsman DG, Miller D, McAlpine JN. Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia. Canada. Am J Obstet Gynecol. 2018;219(2):172 e1-172 e8. https:\/\/doi.org\/10.1016\/j.ajog.2018.05.019.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"7244_CR18","doi-asserted-by":"publisher","first-page":"e2147343","DOI":"10.1001\/jamanetworkopen.2021.47343","volume":"5","author":"GE Hanley","year":"2022","unstructured":"Hanley GE, Pearce CL, Talhouk A, et al. Outcomes from opportunistic salpingectomy for ovarian cancer prevention. JAMA Netw Open. 2022;5(2):e2147343. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.47343.","journal-title":"JAMA Netw Open"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07244-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07244-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07244-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T03:04:08Z","timestamp":1679627048000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07244-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,24]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7244"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07244-w","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2023,3,24]]},"assertion":[{"value":"10 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The HOPPSA study was approved by the Regional ethical review board in Gothenburg September 9, 2016 (Dnr 501\u201316). Amendments September 12, 2016 (Dnr 501\u201316); April 25, 2017 (Dnr T407-17); September 14, 2017 (Dnr T733-17). Each patient consents to participation in the GynOp registry and their inclusion in the trial.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"222"}}